Oxurion
Gaston Geenslaan 1
3001 Leuven
BE
Oxurion
Foundation date
30/05/2006
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Drug delivery
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Therapeutics - Small molecules
- #Therapeutics - Antibodies
Therapeutic areas
Oxurion is dedicated to developing and commercializing new pharmacologic ophthalmic treatments that address important unmet clinical needs. By meeting this goal Oxurion intends to help patients around the world with a new or better treatment for their condition.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
2206 '23
Translational Research in Crops
Event by: VIB
Latest news
More news-
Mithra appoints experienced life sciences executive Christian Homsy* as Chairman
18 hours ago
Read more
-
Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema
Friday May 26th 2023
Read more
-
How garbage disposal clogs in cells can lead to Alzheimer’s
Friday May 26th 2023
Read more
Jobs
More jobs-
30/05/23
Remote, Brussels, Abroad
Executive, Chief Financial Officer - European Operations
Permanent, Freelance
General Inception -
-